Speak to one of our representatives by filling the form below.
The surgical removal of the kidney, renal pelvis (the center part of the kidney that collects urine), ureter (a long tube that drains urine from the kidney into the bladder), and bladder cuff (a small piece of tissue where the ureter connects to the bladder) is known as "Nephroureterectomy." It is a minimally invasive (does not involve extensive incisions or bleeding, with quick recovery) procedure used to treat upper urinary tract transitional cell carcinoma (TCC), also known as urothelial cancer. TCC is a tumor of the renal pelvis and ureter that may also involve the urothelium (the tissue that lines most of the urinary tract, including the renal pelvis, the ureter, and the bladder).
"Nephro" means related to the kidneys; "ureter" is the thin, long tube that collects urine from the renal pelvis and drains it into the bladder; and "ectomy" means to remove a part of the organ. Nephroureterectomy is a minimally-invasive radical removal of the kidney, renal pelvis, the entire ureter, and the bladder cuff.
Nephroureterectomy is always radical surgery, which means your surgeon will remove the tumor along with the organ into which cancer has spread. It is performed through
Urothelial cancer can develop from the tissue lining of the urinary tract (urothelium), which may progress and spread to nearby structures. Symptoms include- hematuria (blood in the urine), unexplained weight loss, an abnormal mass in the kidney area, and persistent backache and fever. These tumors are best removed through a radical (complete) nephroureterectomy through a traditional open approach or other minimally invasive techniques (laparoscopic or robotic-assisted).
Urothelial carcinoma (cancer) causes 90% of all bladder cancers and 7% of all types of kidney cancer (including ureter and kidney pelvis).
Nephroureterectomy has remained the gold standard for surgical management of upper tract transitional cell carcinoma, especially if it is on the aggressive end of the cancer spectrum.
When you notice any symptoms associated with urothelial cancer, schedule an appointment with a urologist (a doctor specializing in urinary tract diseases) and discuss your symptoms.
Nephroureterectomy is an inpatient procedure and requires 1–2 days of hospitalization.
You will be kept under observation in a recovery room following a nephroureterectomy. Your vitals will be monitored, and once they have stabilized, you will be shifted to your room.
At The Hospital
At Home
Nephroureterectomy is the gold standard surgical treatment for aggressive transitional cell carcinoma (urothelial cancer), with a high success rate (up to 95%). The benefits and risks of the procedure are listed below:
Surgery can be a daunting aspect, and feeling anxious is absolutely normal. The massive amount of information you can get from the internet may confuse you even more. This is where Medfin can help. Leave us the hefty task of finding the best hospital, the finest doctor, and the latest procedure at the lowest cost. Let us take charge while you sit back and focus on your health and recovery. Think surgery! Think Medfin!
Insurance Approved
05:30 PM, Wed